The top two skin layers are the epidermis, forming the waterproof barrier, and the dermis, consisting of hair follicles and sweat glands surrounded by connective tissue
Studies indicate its potential role in reducing inflammation, a key player in various diseases
Our methodology included: Reviewed IVY RX public website disclosures and published program information Reviewed FDA guidance on compounded GLP-1 medications, including enforcement discretion policies and safety communications Evaluated program structure, pricing transparency, and safety disclosures as presented on the company's website Did not evaluate effectiveness, outcomes, or patient results Did not perform medical testing or make clinical recommendations This article is educational and presents information for readers to consider when making their own healthcare decisions in consultation with licensed providers
Encouragement of healthy lifestyle changes: The use of this medication often motivates individuals to adopt long-term healthy habits and improve their metabolic health
Azuri, J., Hammerman, A., & Aboalhasan, E
Specific metabolic changes observed during GLP-1 treatment include: Improved insulin sensitivity , allowing cells to use glucose more efficiently Reduced hepatic glucose production , contributing to better glycaemic control Changes in body composition , with loss of both fat mass and some lean tissue Alterations in lipid metabolism , often resulting in improved cholesterol profiles Body composition studies suggest that lean tissue loss typically accounts for approximately 20-30% of total weight lost during GLP-1 therapy, though this varies considerably between individuals and depends on concurrent physical activity and protein intake
